CD274 and neoplasm: A positive PD-L1 expression in tumor cells (≥1%) was significantly associated with shorter survival only in patients with low NLR, while it was not found to have an impact on survival among patients with high NLR; moreover, having a low NLR and a negative PD-L1 expression was independently associated with improved recurrence-free survival and OS in a multivariate model [108].